Clinical Trial

A Registered Cohort Study on SMA

Recruiting
View on ClinicalTrials.gov →
Summary
Spinal muscular atrophy (SMA) is an autosomal recessive disease that causes progressive muscle wasting and weakness due to loss of motor neurons in the spinal cord. This is a registered cohort of spinal muscular atrophy (SMA) type I，II and III in China. This study will provide further insights into the clinical course of SMA including overall survival, demographic characteristics, motor function, respiratory support, feeding and nutritional support, growth and development. The correlation of genotype and phenotype will be conducted.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-07-03.
Status change: Not Yet Recruiting → Recruiting 2019-09-19
Trial Details
NCT Number NCT04010604
Lead Sponsor Wan-Jin Chen
Conditions Spinal Muscular Atrophy
Enrollment 2,000 participants
Start Date 2019-07-01
Primary Completion 2039-12-31 (estimated)
Study Completion 2049-12-31 (estimated)
Updated on ClinicalTrials.gov 2019-09-23